Introduction
Tissue regeneration combines several processes that have a different temporal progress. Consequently, tissue engineering strategies afford scaffolds specifically designed to mediate tissue-scaffold interactions by surface modification with bioactive ligands, or the integration of a drug delivery system. Besides several other synthetic biodegradable polymers, poly(L-lactide) (PLLA) has already been successfully used as scaffold material and as matrix for local drug delivery (LDD) systems because of its relatively good mechanical and manufacturing properties, as well as moderate biocompatibility [1] . However, the biomedical applications of PLLA, especially cell adhesion, are hampered to a certain extent by its low wettability. A promising approach to simultaneously increase the hydrophilicity and provide the PLLA surface with an LDD function is the surface modification via polyelectrolyte-multilayers (PEM), deposited by layer-bylayer deposition (LbL). The principle of multilayer assembly is as follows: a solid substrate with a charged surface is immersed in a solution containing polyelectrolytes of opposite charge leading to deposition of a first polyelectrolyte layer via electrostatic attraction. The resulting coated substrate is immersed in a second solution containing polyelectrolytes of again opposite charge with regard to the substrate surface. By repeating these steps, alternating multilayer assembly is obtained. Due to possibility to use a high variety of polyelectrolytes the properties of LbL films are tunable and thus embedded drugs can be released from the material in a predefined manner. In this study, we investigated the surface modification of PLLA by PEM based on the polycation poly(L-lysine) (PLL) and three different polyanions, like hyaluronic acid (HA), polyacrylic acid (PAA) and chondroitin sulfate (CS). The drug release behavior of biomolecules such as avidin fluorescein isothiocyanate (avidin-FITC) and vascular endothelial growth factor (VEGF) will be discussed in dependence of the used polyanions.
Methods
All chemicals were purchased from Sigma Aldrich, Mallinckrodt Baker, SERVA Feinbiochemica, Thermo Scientific and Merck in p. a. quality or higher. The planar PLLA samples (Resomer L210, Boehringer Ingelheim, Germany) were modified, using plasma etching (PE) electrode in an oxygen (O 2 ) radio frequency (RF) plasma generator (frequency 13.56 MHz, power 100 W, Diener electronic GmbH & Co. KG, Ebhausen, Germany) for 5 min. The polyelectrolyte multilayer films were fabricated according to Shah et al. [2] via a robot (KSV Nima, Espoo, Finland) with the following dipping protocol: 5 min in PLL solution (2 mg/mL in 25 mM sodium acetate buffer pH 5.0), 3 washes (10, 20, 30 s), 5 min in PAA (CS, HA) solution (2 mg/mL in 100 mM sodium acetate buffer pH 5.0), 3 washes (10, 20, 30 s), 10 min in avidin-FITC (40 µg/mL or VEGF 2 µg/mL in 25 mM sodium acetate buffer pH 5.0), 1 wash (10 s) and 5 min in PAA (CS, HA) with 3 washes (10, 20, 30 s). This cycle was repeated to achieve 1 and 5 tetralayer films. Dipped foils were allowed to dry for 48 h at 4 °C. Next, VEGF 165 containing films were fabricated on the PLLA using the same dipping protocol to achieve also 5 tetralayers. Each step of layer by layer process was verified via Contact angles measurements by sessile drop method (Contact Angle System, OCA 20, Dataphysics Instruments GmbH, Filderstadt, Germany) and the morphological changes were examined in a XL30 (Philips, Eindhoven, The Netherlands) scanning electron microscope. The release of avidin-FITC and VEGF from PEM (Ø = 9 mm) in 1 ml PBS (pH 7.4) at 37°C was measured by means of the plate reader FLUOstar Optima (BMG Labtech, Offenburg, Germany) and ELISA (Human VEGF ELISA Kit RayBio®, Hölzel Diagnostika, Köln, Germany), respectively.
Results
All investigated PEM were analysed by means of scanning electron microscopy (SEM) and contact angle measurements. The surface morphology of PLLA is hardly changed after deposition of the PLL-layer (Fig. 1a) whereas the roughness increases with addition of tetralayers (TL) (Fig. 1b,c ) using avidin-FITC as embedded biomolecule. The PEM surface containing VEGF hardly changed after the addition of TLs. The averaged contact angle of un-activated PLLA decreased from 76° to 50.2° after the plasma chemical activation and with deposition of the polycation PLL to 39.3°. The immobilisation of the polyanion (HA, PAA or CS) had a negligible effect to the contact angle. The additional protein-monolayer showed an increase in contact angle, which dropped again with the deposition of the polyanionic cover layer (Fig. 2 ). The influence of the polyanions HA, PAA or CS was investigated by releasing avidin-FITC, as model substrate, from PEMs containing 5 TL. The highest released amount was detected using PAA (1.3 µg) followed by HA (0.39 µg) and CS (0.33 µg). The release profiles for all investigated PEMs were rather similar except for the burst release within the first 24 h (Fig. 3) . The highest burst release was detected for PLLA (PLL-PAA-FITC-PAA) 5 with 50%, followed by PLLA (PLL-HA-FITC-HA) 5 with 32% and PLLA (PLL-CS-FITC-CS) 5 with 30% within the first hour. 
Discussion
The PEM surface morphology, characterized via SEM, revealed that with addition of avidin-FITC the surface of the PEMs got rougher. This effect is probably due to embedded avidin-FITC, which crystallizes after the LBL process during the drying process. Furthermore, the contact angle, detected during the layer by layer process for both biomolecules decreased, indicating a more hydrophilic surface and the deposition of layers on the unactivated PLLA. This decrease is most probably due to the more hydrophilic groups of the used polyelectrolytes. The PAA films contain a relatively high amount and have a high burst release of avidin-FITC compared to the HA and CS films. This is probably caused by the fact that the films constructed with PAA as polyanion yield in highly ionically crosslinked films in contrast to CS, as PAA exhibit higher charge density. Moreover, the release of avidin-FITC and VEGF from the films occurs with a pH shift from pH 5.0 at dipping conditions to physiological pH 7.4 in PBS, due to a combination of destabilization and charge imbalance in the films. Thus, the embedded avidin-FITC and VEGF can be released faster. Moreover, the release profiles showed that avidin-FITC and VEGF is faster released using PAA as polyanion instead of CS, which is probably due to higher interactions between the biomolecules and CS.
Conclusion
Different PEM based on PLLA which differ in the used polyanionic layer and incorporated avidin-FITC or VEGF as model biomolecules, were investigated. The in vitro release studies of avidin-FITC and VEGF demonstrated that the use of HA, PAA or CS seems to have a tunable influence on the released drug amount and the release profile.
